DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Donnan K, Segar L.
SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes.
Eur J Pharmacol 2019;
846: 23-29
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.